Your search for

4 results were returned

  1. Twobirds news
    30 May 2019
    International team advises Chiesi Farmaceutici on in-licence of Raxone® from Santhera
    www.twobirds.com/en/news/press-releases/2019/uk/international-team-advises-chiesi-farmaceutici-on-inlicence-of-raxone-from-santhera

    International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")

  2. Twobirds news
    28 February 2020
    Bird & Bird advises Mitsubishi Chemical Corporation on the acquisition of c-m-p
    www.twobirds.com/en/news/press-releases/2020/germany/bird-beraet-mitsubishi-chemical-corporation

    International law firm Bird & Bird advises Mitsubishi Chemical Advanced Materials (MCAM), a leading global manufacturer of high-performance materials and a business division of Mitsubishi Chemical Corporation, Japan, on ...

  3. Twobirds news
    27 April 2018
    Bird & Bird achieves exceptional results in Legal 500 EMEA 2018
    www.twobirds.com/en/news/press-releases/2018/global/bird-and-bird-achieves-exceptional-results-in-legal-500-emea-2018

    Bird & Bird is delighted to announce that we have received an excellent set of results in the 2018 edition of Legal 500: EMEA. As well as 34 top-tier rankings across our EMEA offices, we were recommended in a further ...